Helius Medical Technologies Inc
General ticker "HSDT" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.1M
Helius Medical Technologies Inc does not follow the US Stock Market performance with the rate: -39.2%.
Estimated limits based on current volatility of 24.2%: low 0.59$, high 0.97$
Factors to consider:
- US accounted for 40.9% of revenue in the fiscal year ended 2022-12-31
- Current price 75.0% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.84$, 11.69$]
- 2024-12-30 to 2025-12-30 estimated range: [2.27$, 7.10$]
Financial Metrics affecting the HSDT estimates:
- Negative: Non-GAAP EPS, $ of -14.46 <= 0.10
- Negative: Operating profit margin, % of -95.07 <= 1.03
- Negative: Operating cash flow per share per price, % of -70.40 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
Short-term HSDT quotes
Long-term HSDT plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.52MM | $0.79MM | $0.64MM |
| Operating Expenses | $18.66MM | $16.30MM | $13.07MM |
| Operating Income | $-18.14MM | $-15.52MM | $-12.43MM |
| Non-Operating Income | $0.01MM | $1.44MM | $3.58MM |
| Interest Expense | $0.00MM | $0.83MM | $0.00MM |
| R&D Expense | $5.99MM | $4.26MM | $2.94MM |
| Income(Loss) | $-18.13MM | $-14.07MM | $-8.85MM |
| Profit(Loss) | $-18.13MM | $-14.07MM | $-8.85MM |
| Stockholders Equity | $11.26MM | $8.15MM | $2.35MM |
| Inventory | $0.48MM | $0.59MM | $0.46MM |
| Assets | $14.10MM | $17.29MM | $7.69MM |
| Operating Cash Flow | $-13.39MM | $-14.31MM | $-10.42MM |
| Capital expenditure | $0.06MM | $0.02MM | $0.03MM |
| Investing Cash Flow | $-0.06MM | $-0.01MM | $-0.03MM |
| Financing Cash Flow | $21.13MM | $17.87MM | $1.08MM |
| Earnings Per Share* | $-368.82 | $-46.52 | $-14.56 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.